ACET
Price
$0.89
Change
-$0.02 (-2.20%)
Updated
Dec 23, 03:53 PM (EDT)
79 days until earnings call
EOLS
Price
$10.84
Change
-$0.05 (-0.46%)
Updated
Dec 23, 04:59 PM (EDT)
65 days until earnings call
Ad is loading...

ACET vs EOLS

Header iconACET vs EOLS Comparison
Open Charts ACET vs EOLSBanner chart's image
Adicet Bio
Price$0.89
Change-$0.02 (-2.20%)
Volume$5.6K
CapitalizationN/A
Evolus
Price$10.84
Change-$0.05 (-0.46%)
Volume$12.57K
CapitalizationN/A
ACET vs EOLS Comparison Chart
Loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EOLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACET vs. EOLS commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a Hold and EOLS is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (ACET: $0.91 vs. EOLS: $10.89)
Brand notoriety: ACET and EOLS are both not notable
ACET represents the Biotechnology, while EOLS is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ACET: 102% vs. EOLS: 161%
Market capitalization -- ACET: $73.55M vs. EOLS: $846.82M
ACET [@Biotechnology] is valued at $73.55M. EOLS’s [@Pharmaceuticals: Other] market capitalization is $846.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 2 FA rating(s) are green whileEOLS’s FA Score has 0 green FA rating(s).

  • ACET’s FA Score: 2 green, 3 red.
  • EOLS’s FA Score: 0 green, 5 red.
According to our system of comparison, ACET is a better buy in the long-term than EOLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 3 TA indicator(s) are bullish while EOLS’s TA Score has 3 bullish TA indicator(s).

  • ACET’s TA Score: 3 bullish, 4 bearish.
  • EOLS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ACET is a better buy in the short-term than EOLS.

Price Growth

ACET (@Biotechnology) experienced а -5.68% price change this week, while EOLS (@Pharmaceuticals: Other) price change was -5.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.12%. For the same industry, the average monthly price growth was -2.88%, and the average quarterly price growth was +3.33%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.39%. For the same industry, the average monthly price growth was -1.09%, and the average quarterly price growth was -8.83%.

Reported Earning Dates

ACET is expected to report earnings on Mar 12, 2025.

EOLS is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-2.12% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Other (-0.39% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EOLS($847M) has a higher market cap than ACET($73.6M). EOLS YTD gains are higher at: 3.419 vs. ACET (-51.852). EOLS has higher annual earnings (EBITDA): -41.81M vs. ACET (-111.35M). ACET has more cash in the bank: 202M vs. EOLS (62.8M). ACET has less debt than EOLS: ACET (18.2M) vs EOLS (127M). EOLS has higher revenues than ACET: EOLS (202M) vs ACET (0).
ACETEOLSACET / EOLS
Capitalization73.6M847M9%
EBITDA-111.35M-41.81M266%
Gain YTD-51.8523.419-1,517%
P/E RatioN/AN/A-
Revenue0202M-
Total Cash202M62.8M322%
Total Debt18.2M127M14%
FUNDAMENTALS RATINGS
ACET vs EOLS: Fundamental Ratings
ACET
EOLS
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
97
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
8763
P/E GROWTH RATING
1..100
22100
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACET's Valuation (33) in the Medical Distributors industry is somewhat better than the same rating for EOLS (97) in the Pharmaceuticals Major industry. This means that ACET’s stock grew somewhat faster than EOLS’s over the last 12 months.

ACET's Profit vs Risk Rating (100) in the Medical Distributors industry is in the same range as EOLS (100) in the Pharmaceuticals Major industry. This means that ACET’s stock grew similarly to EOLS’s over the last 12 months.

ACET's SMR Rating (97) in the Medical Distributors industry is in the same range as EOLS (100) in the Pharmaceuticals Major industry. This means that ACET’s stock grew similarly to EOLS’s over the last 12 months.

EOLS's Price Growth Rating (63) in the Pharmaceuticals Major industry is in the same range as ACET (87) in the Medical Distributors industry. This means that EOLS’s stock grew similarly to ACET’s over the last 12 months.

ACET's P/E Growth Rating (22) in the Medical Distributors industry is significantly better than the same rating for EOLS (100) in the Pharmaceuticals Major industry. This means that ACET’s stock grew significantly faster than EOLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACETEOLS
RSI
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
78%
Momentum
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
88%
MACD
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 15 days ago
82%
Bullish Trend 27 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
80%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
78%
Aroon
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
78%
View a ticker or compare two or three
Ad is loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EOLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBSSX30.700.27
+0.89%
Neuberger Berman Focus Investor
MMCFX13.600.07
+0.52%
AMG Veritas China N
WEMMX15.830.04
+0.25%
TETON Westwood Mighty Mites AAA
FSGGX14.40N/A
N/A
Fidelity Global ex US Index
FMPEX28.09-2.21
-7.29%
Fidelity Advisor Mid Cap Value C

ACET and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACET has been loosely correlated with OGI. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then OGI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
+5.78%
OGI - ACET
41%
Loosely correlated
+6.85%
DVAX - ACET
39%
Loosely correlated
-0.31%
KYMR - ACET
38%
Loosely correlated
+3.88%
CRON - ACET
36%
Loosely correlated
+4.28%
PRTA - ACET
36%
Loosely correlated
-4.93%
More